BP000221-CYT-352: Recombinant Human Leptin Antagonist Triple Mutant
Source: E. Coli-derived.
Purity > 98.0% by Gel filtration analysis and SDS-PAGE.BP000221-CYT-353: Recombinant Human Leptin Antagonist Quadruple Mutant
Source: E. Coli-derived.
ProSpec Leptin Quadruple Antagonist Mutant is capable of inhibiting leptin-induced proliferation of BAF/3 cells stably transected with the long form of human Leptin receptor. It also inhibits various Leptin effects in several in vitro bioassays.
Purity > 98.0% by RP-HPLC and SDS-PAGE.BP000221-CYT-354: Recombinant Mouse Leptin Antagonist Triple Mutant
Source: E. Coli-derived.
Purity > 99.0% as determined by Gel filtration analysis and SDS-PAGE.BP000221-CYT-355: Recombinant Rat Leptin Antagonist Triple Mutant
Source: E. Coli-derived.
ProSpec Leptin Antagonist Triple Mutant Rat Recombinant is capable of inhibiting leptin-induced proliferation of BAF/3 cells stably transfected with the long form of human leptin receptor. It also inhibits various leptin effects in several in vitro bioassays.
Purity > 99.0% as determined by Gel filtration analysis and SDS-PAGE.BP000221-CYT-357: Recombinant Ovine Leptin Antagonist Quadruple Mutant
Source: E. Coli-derived.
ProSpec leptin qA is capable of inhibiting leptin-induced proliferation of BAF/3 cells stably transfected with the long form of ovine leptin receptor. It also inhibits various leptin effects in several in vitro bioassays.
Purity > 98.0% as determined by Gel filtration analysis and SDS-PAGE.BP000221-CYT-566: Recombinant Mouse Leptin Antagonist Triple Mutant Pegylated
Source: E. Coli-derived.
Purity > 99.0% as determined by Gel filtration analysis and SDS-PAGE.BP000221-CYT-567: Recombinant Rat Leptin Antagonist Triple Mutant Pegylated
Source: E. Coli-derived.
Purity > 99.0% as determined by Gel filtration analysis and SDS-PAGE.BP000221-CYT-702: Recombinant Human Leptin Antagonist Triple Mutant Pegylated
Source: E. Coli-derived.
Capable of inhibiting leptin-induced proliferation of BAF/3 cells stably transfected with the long form of human leptin receptor. Its in vitro activity is 6-8 fold lower than the non-pegylated antagonist but in vivo it has profound weight gain effect (as compared to the non-pegylated antagonist), resulting mainly from increased food intake. Its in vivo activity compared to that of PEG-MLA is 9-27 fold higher.
Purity > 98.0% by Gel filtration analysis and SDS-PAGE.BP000221-CYT-703: Recombinant Ovine Leptin Antagonist Triple Mutant Pegylated
Source: E. Coli-derived.
Purity > 95.0% as determined by Gel filtration analysis and SDS-PAGE.